Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2026-01-02 @ 11:19 PM
Study NCT ID:
NCT00086658
Status:
COMPLETED
Last Update Posted:
2020-05-05
First Post:
2004-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03-23
Start Date Type:
ACTUAL
Primary Completion Date:
2006-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-07
First Submit QC Date:
None
Study First Post Date:
2004-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-01
Last Update Post Date:
2020-05-05
Last Update Post Date Type:
ACTUAL